{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T03:06:49Z","timestamp":1790651209577,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002402","name":"Sun Yat-Sen University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002402","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.vaccine.2024.02.027","type":"journal-article","created":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T09:56:34Z","timestamp":1709114194000},"page":"2072-2080","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Rapid and highly potent humoral responses to mpox nanovaccine candidates adjuvanted by thermostable scaffolds"],"prefix":"10.1016","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4316-7017","authenticated-orcid":false,"given":"Haozhen","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-9118-4955","authenticated-orcid":false,"given":"Yuanli","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinsong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruihao","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1117-0519","authenticated-orcid":false,"given":"XiangNing","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JiaYue","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HuaiMin","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuying","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinsong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingwei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinrui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenyang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeliang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"19","key":"10.1016\/j.vaccine.2024.02.027_b0005","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1056\/NEJMra2208860","article-title":"Monkeypox[J]","volume":"387","author":"Gessain","year":"2022","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.vaccine.2024.02.027_b0010","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1007\/s40265-022-01742-y","article-title":"Prevention and Treatment of Monkeypox[J]","volume":"82","author":"Rizk","year":"2022","journal-title":"Drugs"},{"issue":"5","key":"10.1016\/j.vaccine.2024.02.027_b0015","first-page":"593","article-title":"A human infection caused by monkeypox virus in Basankusu Territory, Democratic Republic of the Congo[J]","volume":"46","author":"Ladnyj","year":"1972","journal-title":"Bull World Health Organ"},{"issue":"2","key":"10.1016\/j.vaccine.2024.02.027_b0020","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.patbio.2008.02.006","article-title":"Human monkeypox][J","volume":"57","author":"Chastel","year":"2009","journal-title":"Pathol Biol (Paris)"},{"issue":"11","key":"10.1016\/j.vaccine.2024.02.027_b0025","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1016\/j.vaccine.2020.01.058","article-title":"A randomized phase II trial to compare safety and immunogenicity of the MVA-BN smallpox vaccine at various doses in adults with a history of AIDS[J]","volume":"38","author":"Overton","year":"2020","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2024.02.027_b0030","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1586\/14760584.8.1.13","article-title":"IMVAMUNE: modified vaccinia Ankara strain as an attenuated smallpox vaccine[J]","volume":"8","author":"Kennedy","year":"2009","journal-title":"Expert Rev Vaccines"},{"issue":"4","key":"10.1016\/j.vaccine.2024.02.027_b0035","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.4049\/jimmunol.177.4.2552","article-title":"Subunit Recombinant Vaccine Protects against Monkeypox[J]","volume":"177","author":"Heraud","year":"2006","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2024.02.027_b0040","article-title":"Monkeypox in human pregnancy: an overview[J]","volume":"2","author":"Daneji","year":"2022","journal-title":"AJOG Glob Rep"},{"issue":"9","key":"10.1016\/j.vaccine.2024.02.027_b0045","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1038\/s41587-022-01463-3","article-title":"Monkeypox response relies on three vaccine suppliers[J]","volume":"40","author":"Harrison","year":"2022","journal-title":"Nat Biotechnol"},{"issue":"1","key":"10.1016\/j.vaccine.2024.02.027_b0050","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1600-065X.2010.00975.x","article-title":"Smallpox vaccines: targets of protective immunity[J]","volume":"239","author":"Moss","year":"2011","journal-title":"Immunol Rev"},{"issue":"3","key":"10.1016\/j.vaccine.2024.02.027_b0055","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.cell.2016.09.049","article-title":"Cross-Neutralizing and Protective Human Antibody Specificities to Poxvirus Infections[J]","volume":"167","author":"Gilchuk","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2024.02.027_b0060","first-page":"1","article-title":"Real-world effectiveness of a single dose of mpox vaccine in males[J]","author":"Sagy","year":"2023","journal-title":"Nat Med"},{"issue":"20","key":"10.1016\/j.vaccine.2024.02.027_b0065","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1001\/jama.2022.18320","article-title":"Human Monkeypox Virus Infection in the Immediate Period After Receiving Modified Vaccinia Ankara Vaccine[J]","volume":"328","author":"Hazra","year":"2022","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.vaccine.2024.02.027_b0070","first-page":"819","article-title":"FDA Authorizes Intradermal Vaccine, Streamlines Rules to Increase Monkeypox Treatment Access[J]","volume":"328","author":"Larkin","year":"2022","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.vaccine.2024.02.027_b0075","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41591-022-02090-w","article-title":"Low levels of monkeypox virus-neutralizing antibodies after MVA-BN vaccination in healthy individuals[J]","volume":"29","author":"Zaeck","year":"2023","journal-title":"Nat Med"},{"issue":"38","key":"10.1016\/j.vaccine.2024.02.027_b0080","doi-asserted-by":"crossref","first-page":"6007","DOI":"10.1016\/j.vaccine.2020.07.018","article-title":"Short-term and longer-term protective immune responses generated by subunit vaccination with smallpox A33, B5, L1 or A27 proteins adjuvanted with aluminum hydroxide and CpG in mice challenged with vaccinia virus[J]","volume":"38","author":"Xiao","year":"2020","journal-title":"Vaccine"},{"issue":"18","key":"10.1016\/j.vaccine.2024.02.027_b0085","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1001\/jama.2022.18452","article-title":"Single Monkeypox Vaccine Dose Provides Some Protection[J]","volume":"328","author":"Kuehn","year":"2022","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.vaccine.2024.02.027_b0090","doi-asserted-by":"crossref","DOI":"10.3390\/v15010103","article-title":"Monkeypox and Other Human Orthopoxvirus Infections[J]","volume":"15","author":"Shchelkunova","year":"2022","journal-title":"Viruses"},{"issue":"2","key":"10.1016\/j.vaccine.2024.02.027_b0095","doi-asserted-by":"crossref","first-page":"88","DOI":"10.32607\/20758251-2017-9-2-88-93","article-title":"Comparing New-Generation Candidate Vaccines against Human Orthopoxvirus Infections[J]","volume":"9","author":"Maksyutov","year":"2017","journal-title":"Acta Nat"},{"issue":"40","key":"10.1016\/j.vaccine.2024.02.027_b0100","doi-asserted-by":"crossref","first-page":"6627","DOI":"10.1016\/j.vaccine.2010.07.030","article-title":"A protein-based smallpox vaccine protects non-human primates from a lethal monkeypox virus challenge[J]","volume":"28","author":"Buchman","year":"2010","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2024.02.027_b0105","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/nm1261","article-title":"Smallpox vaccine-induced antibodies are necessary and sufficient for protection against monkeypox virus[J]","volume":"11","author":"Edghill-Smith","year":"2005","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.vaccine.2024.02.027_b0110","first-page":"41","article-title":"The use of vaccinia hyperimmune gamma-globulin in the prophylaxis of smallpox[J]","volume":"25","author":"Kempe","year":"1961","journal-title":"Bull World Health Organ"},{"issue":"19","key":"10.1016\/j.vaccine.2024.02.027_b0115","doi-asserted-by":"crossref","first-page":"10230","DOI":"10.1128\/JVI.78.19.10230-10237.2004","article-title":"Protective immunity to vaccinia virus induced by vaccination with multiple recombinant outer membrane proteins of intracellular and extracellular virions[J]","volume":"78","author":"Fogg","year":"2004","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2024.02.027_b0120","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0042-6822(02)00038-7","article-title":"Four-gene-combination DNA vaccine protects mice against a lethal vaccinia virus challenge and elicits appropriate antibody responses in nonhuman primates[J]","volume":"306","author":"Hooper","year":"2003","journal-title":"Virology"},{"issue":"9","key":"10.1016\/j.vaccine.2024.02.027_b0125","doi-asserted-by":"crossref","first-page":"4433","DOI":"10.1128\/JVI.78.9.4433-4443.2004","article-title":"Smallpox DNA vaccine protects nonhuman primates against lethal monkeypox[J]","volume":"78","author":"Hooper","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2024.02.027_b0130","doi-asserted-by":"crossref","first-page":"1042997","DOI":"10.3389\/fimmu.2022.1042997","article-title":"Immunoinformatic-based design of immune-boosting multiepitope subunit vaccines against monkeypox virus and validation through molecular dynamics and immune simulation[J]","volume":"13","author":"Suleman","year":"2022","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2024.02.027_b0135","doi-asserted-by":"crossref","first-page":"e3850","DOI":"10.1371\/journal.pntd.0003850","article-title":"BoHV-4-Based Vector Single Heterologous Antigen Delivery Protects STAT1(-\/-) Mice from Monkeypoxvirus Lethal Challenge[J]","volume":"9","author":"Franceschi","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2024.02.027_b0140","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.virol.2014.06.039","article-title":"A highly specific monoclonal antibody against monkeypox virus detects the heparin binding domain of A27[J]","volume":"464\u2013465","author":"Hughes","year":"2014","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2024.02.027_b0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.biotechadv.2020.107547","article-title":"The biomedical and bioengineering potential of protein nanocompartments[J]","volume":"41","author":"Demchuk","year":"2020","journal-title":"Biotechnol Adv"},{"issue":"10","key":"10.1016\/j.vaccine.2024.02.027_b0150","doi-asserted-by":"crossref","first-page":"e275487","DOI":"10.1371\/journal.pone.0275487","article-title":"Cryo-electron structures of the extreme thermostable enzymes Sulfur Oxygenase Reductase and Lumazine Synthase[J]","volume":"17","author":"Sobhy","year":"2022","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.vaccine.2024.02.027_b0155","doi-asserted-by":"crossref","first-page":"3543","DOI":"10.1039\/C8CS00154E","article-title":"Tailoring lumazine synthase assemblies for bionanotechnology[J]","volume":"47","author":"Azuma","year":"2018","journal-title":"Chem Soc Rev"},{"issue":"89","key":"10.1016\/j.vaccine.2024.02.027_b0160","doi-asserted-by":"crossref","first-page":"48596","DOI":"10.1039\/C4RA10187A","article-title":"Lumazine synthase protein cage nanoparticles as modular delivery platforms for targeted drug delivery[J]","volume":"4","author":"Min","year":"2014","journal-title":"RSC Adv"},{"issue":"6","key":"10.1016\/j.vaccine.2024.02.027_b0165","article-title":"Development of a Modular Vaccine Platform for Multimeric Antigen Display Using an Orthobunyavirus Model[J]","volume":"9","author":"Aebischer","year":"2021","journal-title":"Vaccines (Basel)"},{"issue":"4","key":"10.1016\/j.vaccine.2024.02.027_b0170","doi-asserted-by":"crossref","first-page":"175","DOI":"10.5483\/BMBRep.2022.55.4.137","article-title":"Application of periostin peptide-decorated self-assembled protein cage nanoparticles for therapeutic angiogenesis[J]","volume":"55","author":"Kim","year":"2022","journal-title":"BMB Rep"},{"issue":"10","key":"10.1016\/j.vaccine.2024.02.027_b0175","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.tibtech.2014.08.001","article-title":"Superglue from bacteria: unbreakable bridges for protein nanotechnology[J]","volume":"32","author":"Veggiani","year":"2014","journal-title":"Trends Biotechnol"},{"issue":"12","key":"10.1016\/j.vaccine.2024.02.027_b0180","doi-asserted-by":"crossref","first-page":"E690","DOI":"10.1073\/pnas.1115485109","article-title":"Peptide tag forming a rapid covalent bond to a protein, through engineering a bacterial adhesin[J]","volume":"109","author":"Zakeri","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"17","key":"10.1016\/j.vaccine.2024.02.027_b0185","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/j.vaccine.2016.11.097","article-title":"The origins of the vaccine cold chain and a glimpse of the future[J]","volume":"35","author":"Lloyd","year":"2017","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2024.02.027_b0190","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1007\/s12098-017-2555-2","article-title":"Vaccinations in Primary Care[J]","volume":"85","author":"Shukla","year":"2018","journal-title":"Indian J Pediatr"},{"key":"10.1016\/j.vaccine.2024.02.027_b0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2023.105668","article-title":"Mpox virus mRNA-lipid nanoparticle vaccine candidates evoke antibody responses and drive protection against the Vaccinia virus challenge in mice[J]","volume":"216","author":"Xia","year":"2023","journal-title":"Antiviral Res"},{"issue":"716","key":"10.1016\/j.vaccine.2024.02.027_b0200","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adg3540","article-title":"An mpox virus mRNA-lipid nanoparticle vaccine confers protection against lethal orthopoxviral challenge[J]","volume":"15","author":"Freyn","year":"2023","journal-title":"Sci Transl Med"},{"issue":"12","key":"10.1016\/j.vaccine.2024.02.027_b0205","doi-asserted-by":"crossref","first-page":"10126","DOI":"10.1128\/JVI.72.12.10126-10137.1998","article-title":"The vaccinia virus 14-kilodalton (A27L) fusion protein forms a triple coiled-coil structure and interacts with the 21-kilodalton (A17L) virus membrane protein through a C-terminal alpha-helix[J]","volume":"72","author":"Vazquez","year":"1998","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2024.02.027_b0210","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1128\/JVI.72.2.1577-1585.1998","article-title":"A27L protein mediates vaccinia virus interaction with cell surface heparan sulfate[J]","volume":"72","author":"Chung","year":"1998","journal-title":"J Virol"},{"issue":"17","key":"10.1016\/j.vaccine.2024.02.027_b0215","doi-asserted-by":"crossref","first-page":"8687","DOI":"10.1128\/JVI.00852-08","article-title":"Vaccinia virus l1 protein is required for cell entry and membrane fusion[J]","volume":"82","author":"Bisht","year":"2008","journal-title":"J Virol"},{"issue":"6","key":"10.1016\/j.vaccine.2024.02.027_b0220","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.1128\/jvi.70.6.3753-3762.1996","article-title":"Extracellular vaccinia virus envelope glycoprotein encoded by the A33R gene[J]","volume":"70","author":"Roper","year":"1996","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2024.02.027_b0225","doi-asserted-by":"crossref","first-page":"19234","DOI":"10.1038\/srep19234","article-title":"Plug-and-Display: decoration of Virus-Like Particles via isopeptide bonds for modular immunization[J]","volume":"6","author":"Brune","year":"2016","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.vaccine.2024.02.027_b0230","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1021\/acs.bioconjchem.7b00174","article-title":"Dual Plug-and-Display Synthetic Assembly Using Orthogonal Reactive Proteins for Twin Antigen Immunization[J]","volume":"28","author":"Brune","year":"2017","journal-title":"Bioconjug Chem"},{"issue":"6","key":"10.1016\/j.vaccine.2024.02.027_b0235","article-title":"Development of a Modular Vaccine Platform for Multimeric Antigen Display Using an Orthobunyavirus Model[J]","volume":"9","author":"Aebischer","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2024.02.027_b0240","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2147\/IJN.S387160","article-title":"A Multivalent and Thermostable Nanobody Neutralizing SARS-CoV-2 Omicron (B.1.1.529)[J]","volume":"18","author":"Lu","year":"2023","journal-title":"Int J Nanomedicine"},{"issue":"4","key":"10.1016\/j.vaccine.2024.02.027_b0245","first-page":"239","article-title":"Duration of neutralizing antibody persisting in Thai individuals after childhood vaccination against smallpox[J]","volume":"35","author":"Kwanchum","year":"2017","journal-title":"Asian Pac J Allergy Immunol"},{"issue":"12","key":"10.1016\/j.vaccine.2024.02.027_b0250","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.amjmed.2008.08.019","article-title":"Immunity from smallpox vaccine persists for decades: a longitudinal study[J]","volume":"121","author":"Taub","year":"2008","journal-title":"Am J Med"},{"issue":"9","key":"10.1016\/j.vaccine.2024.02.027_b0255","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1016\/j.xphs.2018.05.002","article-title":"Biomedical Applications of Lumazine Synthase[J]","volume":"107","author":"Wei","year":"2018","journal-title":"J Pharm Sci"},{"issue":"1","key":"10.1016\/j.vaccine.2024.02.027_b0260","doi-asserted-by":"crossref","first-page":"18149","DOI":"10.1038\/s41598-020-74949-2","article-title":"A platform incorporating trimeric antigens into self-assembling nanoparticles reveals SARS-CoV-2-spike nanoparticles to elicit substantially higher neutralizing responses than spike alone[J]","volume":"10","author":"Zhang","year":"2020","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.vaccine.2024.02.027_b0265","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1080\/22221751.2020.1760735","article-title":"Particulate multivalent presentation of the receptor binding domain induces protective immune responses against MERS-CoV[J]","volume":"9","author":"Okba","year":"2020","journal-title":"Emerg Microbes Infect"},{"issue":"5","key":"10.1016\/j.vaccine.2024.02.027_b0270","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.chembiol.2022.02.004","article-title":"Resurfaced ZIKV EDIII nanoparticle immunogens elicit neutralizing and protective responses in vivo[J]","volume":"29","author":"Georgiev","year":"2022","journal-title":"Cell Chem Biol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24001737?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24001737?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T06:41:00Z","timestamp":1714977660000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X24001737"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":54,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S0264410X24001737"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.02.027","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rapid and highly potent humoral responses to mpox nanovaccine candidates adjuvanted by thermostable scaffolds","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.02.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}